ask our doctors

Conduction Blocks

Get the facts on Conduction Blocks treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Conduction Blocks prevention, screening, research, statistics and other Conduction Blocks related topics. We answer all your qestions about Conduction Blocks.

Question: could any one tell about the disease multifocal motor nerve conduction blocks is there any treatment for cure my father has been suffering from this disease from the past 2 years , it has increased slowly from finger and now entire body is affected.we have spent so much of money for his treatment but rather it grew worse.can any one suggest any doctor or hospital for his complete treatment.

Answer: well ur father needs consultation with a neurologist... divya are u from india?its very costly treatment....without insurance i may say Most patients maintain productive lives despite ongoing symptoms, and up to 94% remain employed. Gradual progression of symptoms may lead to significant disability. MMN is an immune-mediated disorder, and while multiple immunomodulatory and immunosuppressive treatments have been used, only intravenous IVIG and cyclophosphamide have been consistently effective. Anecdotal reports also indicate that rituximab, interferon-beta, azathioprine, and cyclosporine may be efficacious. Cyclophosphamide may be used in combination with plasmapheresis. Corticosteroids or plasmapheresis (without cyclophosphamide) is not effective, and in some cases, MMN may even worsen. Recent reports describe effective treatment with cyclosporine and rituximab in a small number of patients, but additional data are needed before these would be recommended for treatment of MMN. Other treatments used with variable success include interferon-beta and azathioprine. * Most patients are treated as outpatients, although they may have to be admitted with severe exacerbations. Further Outpatient Care: * Outpatient care consists of clinic visits to neurologists, physiatrists, and occupational and physical therapists. In/Out Patient Meds: * IVIG infusions are usually administered on an outpatient basis in the physician's office or at home. * Prognosis is usually good, and 70-80% of patients respond to treatment. Even in patients who do not respond to therapy, weakness is only slowly progressive and up to 94% of patients remain employed.

Conduction Blocks News